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Anesthetic-induced neurodegeneration in rats occurs across the first three postnatal weeks1 
(human equivalent: fetus to pre-schooler), during which the central nervous system, 
respiratory control and pharmacodynamics undergo huge changes. In immature rats, 
hypercarbia alone (mimicking isoflurane anesthesia-induced hypercarbia) induced 
neurodegeneration2 and Xenon reduces anesthetic-induced neurodegeneration3. 
To facilitate comparison of equipotent anesthetic mixtures of sevoflurane and Xenon, we 
aimed to measure the mean concentration of sevoflurane +/- 50% Xenon preventing 
purposeful movement in 50% of immature rats (MACsevo and MACsevoXe) on postnatal 
days (P)5, 10 and 15. 50% Xenon was used as it is clinically useful; offering potential 
neuroprotection and delivery with up to 50% oxygen.
These experiments were carried out and approved under Home Office License and with 
University ethical approval. For the measurement of MACsevo and MACsevoXe, three, 
mixed-sex, rats of equal age were exposed to: 3.0% sevoflurane or 2.5% sevoflurane in 50% 
Xenon, respectively (estimated, a-priori, as MAC). Gasses were delivered using calibrated, 
low flow, rotameters and monitoring ensured that CO2 rebreathing was limited to 2%. After 
30 minutes, a 50mm bulldog clamp was applied to the mid-portion of the tails until 
purposeful movement was seen (or 30secs maximum). According with the up-and-down 
method, this response rate dictated the concentration the subsequent three animals were 
exposed to (i.e. where 2 or 3 animals moved, the concentration was increased by 0.2% or 
0.4%, respectively, and vice versa). In this way, nine doses of sevoflurane +/- Xenon were 
administered to each age group and doses 2-9 (dictated by rat responses) were used to 
calculate a mean: MAC (SD).






























































In further experiments, groups of six rats on P5, 10 and 15, were randomised to two-hour 
exposures to: MACsevo, MACsevoXe, sevoflurane alone in equal concentration to 
MACsevoXe (sevoControl) or 30% oxygen alone (Control). Respiratory rate was monitored 
throughout. Immediate decapitation allowed collection of mixed arterio-venous blood for 
analysis. Unless severe circulatory failure is present, the mean difference between venous 
and arterial pH and partial pressure of CO2 (PCO2) is negligible4. We defined acidosis as 
pH<7.35 and normal lactate as <3.0mmol/L.
An independent samples T-test was used to compare MACsevo with MACsevoXe at each 
age. ANOVA with Tamhane’s post-hoc test (equal variance not assumed) was used to 
compare differences in MAC across the three ages and differences in physiology between 
treatment groups. 
Results
MACsevo (SD) was higher on P10: 3.83% (0.42) than P5: 3.24% (0.27) (p<0.001), and P15: 
3.28% (0.30) (p<0.001) and higher than MACsevoXe (SD) on P5, P10 and P15: 2.26% (0.22) 
(p<0.001), 2.39% (0.26) (p<0.001) and 2.37% (0.22) (p<0.001) with no age-difference. Of 
note, five pups on P5 died (all exposed to the highest concentrations used). They were 
allocated as no response to tail clamping for calculations (excluding them changed MAC 
slightly, but not the statistical comparisons).
The physiology results are presented in the Figure. Blood was successfully analysed from 
65/72 animals (lactate in 57). In the Control group pH was normal at all ages. 53/54 animals 
exposed to sevoflurane +/- Xenon survived but were acidotic. A dose effect, where 
sevoflurane alone lowered RR, was seen at all ages. However, this effect was only seen in 
PCO2 and pH on P5 and P10. Differences between the MAC groups were only seen on P10.






























































Only animals in the MACsevoXe groups had raised lactate (three on P5 with pH 6.72-6.82, 
lactate 8.22-10.03mmol/L, one on P10 with pH 7.05, lactate 3.02mmol/L). An additional 
group was therefore exposed on P5 and showed similar results.
Conclusions
MACsevo was higher on P10 than P5 and P15, in keeping with another rat study5 and with 
humans (peaking during infancy). 50% Xenon had a significant sevoflurane-sparing effect. 
Respiratory depression and acidosis were severe, but comparable between MACsevo and 
MACsevoXe, potentially enabling robust comparison of any neuroprotective effect in future. 
In the younger animals, respiratory depression was marked, and co-administration of Xenon 
and sevoflurane appeared to increase lactate. On P15 there is evidence that the rats were 
better able to compensate for respiratory depression. The physiological derangements 
shown in our study highlight the need for large animal models for optimal translation to the 
clinic. 
References
1. Walters JL, Paule MG. Review of preclinical studies on pediatric general 
anesthesia-induced developmental neurotoxicity. Neurotoxicol Teratol. 
2017;60:2-23.
2. Stratmann G, May LD, Sall JW, et al. Effect of hypercarbia and 
isoflurane on brain cell death and neurocognitive dysfunction in 7-day-
old rats. Anesthesiology. 2009;110(4):849-861.
3. Ma D, Williamson P, Januszewski A, et al. Xenon mitigates isoflurane-
induced neuronal apoptosis in the developing rodent brain. 
Anesthesiology. 2007;106(4):746-753.
4. Adrogue HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Assessing 
Acid-Base Status in Circulatory Failure - Differences between Arterial 






























































and Central Venous-Blood. New England Journal of Medicine. 
1989;320(20):1312-1316.
5. Orliaguet G, Vivien B, Langeron O, Bouhemad B, Coriat P, Riou B. 
Minimum alveolar concentration of volatile anesthetics in rats during 
postnatal maturation. Anesthesiology. 2001;95(3):734-739.
Figure legend:
Median (IQR and range) of the average respiratory rates, and the partial pressure of CO2 
(PCO2), pH and lactate concentration in mixed arterio-venous blood taken from immature 
rats at three ages (postnatal days (P)5, 10 and 15), during and immediately after two-hour 
exposures to: 30% oxygen alone (Control), sevoControl (sevoflurane alone in equal 
concentration to that in MACsevoXe), MACsevo, or MACsevoXe. 
The differences between the exposure groups at each age were tested using one-way 
analysis of variance (P value shown in each panel and significant differences from Control 
(*), sevoControl (ⱡ), or MACsevo (Ω) are shown (Tamhane’s post hoc test). An open circle or 
star represents individual outliers and extreme outliers, respectively.































































Median (IQR and range) of the average respiratory rates, and the partial pressure of CO2 (PCO2), pH and 
lactate concentration in mixed arterio-venous blood taken from immature rats at three ages (postnatal days 
(P)5, 10 and 15), during and immediately after two-hour exposures to: 30% oxygen alone (Control), 
sevoControl (sevoflurane alone in equal concentration to that in MACsevoXe), MACsevo, or MACsevoXe. 
The differences between the exposure groups at each age were tested using one-way analysis of variance (P 
value shown in each panel and significant differences from Control (*), sevoControl (ⱡ), or MACsevo (Ω) are 
shown (Tamhane’s post hoc test). An open circle or star represents individual outliers and extreme outliers, 
respectively. 
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